

Prof Angela Tincani
Professor Angela Tincani is a senior consultant (previously director) at the Rheumatology and Clinical Immunology Unit of Aziende Socio Sanitaria Territoriali (ASST)-Spedali Civili and University of Brescia, Italy.
Professor Tincani has been involved in several international committees for education and research in the field of systemic autoimmune diseases. Professor Tincani’s primary clinical and research interests include the use of anti-rheumatic drugs in pregnant and lactating patients and the management of pregnancy in rheumatic disease patients, in addition to evaluating autoantibodies and autoimmune diseases as risk factors for poor gestational outcomes. She served as an expert for several European Alliance of Associations for Rheumatology (EULAR) recommendations, including “Points to consider for use of anti-rheumatic drugs before pregnancy and during pregnancy and lactation”. Together with Professor Andreoli, Professor Tincani is co-principal investigator of the “Italian Registry of Pregnancy in Rheumatic Diseases”.
Support patients with this wound care guide including practical tips, dressing pros/cons and guidance for routine HS lesions
Master the new S2k HS guidelines. Download this quick guide for key updates and printable treatment algorithms to optimise patient care

Navigating the new European S2k guidelines for hidradenitis suppurativa: How will they change your clinical practice?
Unlock the European S2k HS guidelines. Prof. Tzellos and Prof. Bechara share expert insights and implications of the updated guidelines

Setting up MDT care in HS: Learning from psoriasis
Establishing a multidisciplinary team to alleviate disease burden and optimise patient outcomes, using the principles of value-based healthcare

Use of imaging in HS management
Transformative role of ultrasound and magnetic resonance imaging in HS management, and how AI-driven technologies may enhance disease characterisation

Evidence-based approach to medical management based on the European guidelines for HS
Latest evidence-based strategies for effective HS medical management including antibiotics and biologic therapy